Concordancia inter e intraobservador en la medida de los agujeros maculares por tomografía de coherencia óptica / Inter- and intra-observer agreement in the measurement of macular holes by optical coherence tomography

Antecedentes y objetivo El agujero macular de espesor completo (AMEC) es una lesión foveal causada por un defecto del espesor completo de la retina neurosensorial. En su diagnóstico y en la indicación de tratamiento quirúrgico se tiene en cuenta la medida del agujero según la herramienta proporcionada por la OCT. Dicha medida puede ser realizada por varios oftalmólogos a lo largo del seguimiento de un paciente. El objetivo de este estudio es averiguar si existe variabilidad intraindividual e interindividual en dichas mediciones. Material y métodos Revisión retrospectiva de imágenes de b-scans de OCT con diagnóstico de AMEC. Se realizaron mediciones del diámetro mínimo del AMEC mediante la herramienta manual disponible en el DRI-Triton (Topcon, Japón) en las escalas 1:1 y 1:2, en días diferentes, por 2 especialistas en retina y 2 residentes. Se compararon dichas mediciones para valorar la correspondencia interobservador e intraobservador Resultados Se analizan 34 imágenes. Para la variabilidad intraobservador se obtuvo un índice de correlación superior a 0,98 en todos los casos. Para la variabilidad interobservador, el coeficiente de correlación intraclase fue de 0,94 (IC del 95%, 0,91-0,97) para la escala 1:1, y de 0,94 (IC del 95%, 0.91-0,97) para la escala 1:2. Conclusiones Los valores del tamaño de los AMEC medidos por OCT son reproducibles entre oftalmólogos especialistas y residentes y son independientes de la escala de la imagen en la que se realice dicha medición (AU)

Background and objective A full-thickness macular hole (FTMH) is a foveal lesion caused by a defect in the full thickness of the neurosensory retina. Its diagnosis and the indication for surgical treatment take into account the measurement of the hole according to the tool provided by the OCT. This measurement can be performed by several ophthalmologists during the follow-up of a patient. The aim of this study is to find out whether there is intra-individual and inter-individual variability in these measurements. Material and methods Retrospective review of OCT b-scan images with a diagnosis of FTMH. Measurements of the minimum diameter of the FTMH were performed using the hand-held tool available on the DRI-Triton (Topcon, Japan) at 1:1 and 1:2 scales, on different days, by 2retina specialists and 2residents. These measurements were compared to assess inter-observer and intra-observer correspondence. Results Thirty-four images were analysed. For intra-observer variability, a correlation index higher than 0.98 was obtained in all cases. For inter-observer variability, the intra-class correlation coefficient was 0.94 (95% CI: 0.91-0.97) for the 1:1 scale, and 0.94 (95% CI: 0.91-0.97) for the 1:2 scale. Conclusions OCT-measured AMEC size values are reproducible between ophthalmic specialists and residents and are independent of the imaging scale at which the measurement is made (AU)

Inter- and intra-observer agreement in the measurement of macular holes by optical coherence tomography.

BACKGROUND AND OBJECTIVE: A full-thickness macular hole ("FTMH") is a foveal lesion caused by a defect in the full thickness of the neurosensory retina. Its diagnosis and the indication for surgical treatment take into account the measurement of the hole according to the tool provided by the OCT. This measurement can be performed by several ophthalmologists during the follow-up of a patient. The aim of this study is to find out whether there is intra-individual and inter-individual variability in these measurements. MATERIAL AND METHODS: Retrospective review of OCT b-scan images with a diagnosis of FTMH. Measurements of the minimum diameter of the FTMH were performed using the hand-held tool available on the DRI-Triton (Topcon, Japan) at 1:1 and 1:2 scales, on different days, by 2 retina specialists and 2 residents. These measurements were compared to assess inter-observer and intra-observer correspondence. RESULTS: Thirty-four images were analysed. For intra-observer variability, a correlation index higher than 0.98 was obtained in all cases. For inter-observer variability, the intra-class correlation coefficient was 0.94 (95% CI: 0.91-0.97) for the 1:1 scale, and 0.94 (95% CI: 0.91-0.97) for the 1:2 scale. CONCLUSIONS: OCT-measured AMEC size values are reproducible between ophthalmic specialists and residents and are independent of the imaging scale at which the measurement is made.

Complicaciones intracraneales graves secundarias a infecciones por Streptococcus intermedius / Serious intracranial complications secondary to Streptococcus intermedius infections

Streptococcus intermedius es un microorganismo anaerobio, perteneciente al grupo de Streptococcus anginosus. Es una bacteria comensal habitual de la cavidad oral y nasofaringe, conocida por su potencial capacidad de formar abscesos cerebrales por contigüidad o por vía hematógena a partir de infecciones de la esfera otorrinolaringológica. Las infecciones del sistema nervioso central debidas a miembros de este grupo son potencialmente mortales y requieren de un manejo multidisciplinar. La obtención de imágenes mediante tomografía computarizada o resonancia magnética debe realizarse de forma precoz para evaluar las colecciones que requieren drenaje. La intervención quirúrgica y el inicio de terapia antibiótica empírica a tiempo son imprescindibles para asegurar una correcta evolución (AU)

treptococcus intermedius is an anaerobic bacterium and a member of the Streptococcus anginosus group. It is a commensal bacterium of the oral cavity and nasopharynx, which is known for its potential ability to form brain abscesses by contiguity or hematogenous dissemination from infections of the otorhinolaryngological sphere. Central nervous system infections due to members of this group are life-threatening and need multidisciplinary management. Imaging with computed tomography or magnetic resonance imaging should be performed as soon as possible to evaluate the collections requiring drainage. Timely initiation of surgical intervention and appropriate empirical antibiotic therapy are essential to ensure a correct evolution. (AU)

Comportamiento de los fluidos tamponadores migrados a cámara anterior / Behaviour of buffer fluids migrated to the anterior chamber

Una complicación del uso de fluidos tamponadores en la cirugía vitreorretiniana es la posible migración a cámara anterior (CA).

Endoftalmitis de inicio tardío asociada a ampolla de filtración por Moraxella nonliquefaciens / Delayed-onset bleb-related endophthalmitis caused by Moraxella nonliquefaciens

Las endoftalmitis asociadas a la ampolla de filtración tras cirugía filtrante de glaucoma son poco frecuentes, de inicio tardío y la mayoría están asociadas a una blebitis. Los agentes causales suelen ser estreptococos o bacterias gramnegativas. Existen pocos casos descritos en la literatura de endoftalmitis causada por Moraxella nonliquefaciens y la mayoría están asociados a una blebitis tras cirugía filtrante de glaucoma. Presentamos el caso de una paciente de 90 años con endoftalmitis en ojo derecho por Moraxella nonliquefaciens asociada a blebitis 10 años después de la cirugía de glaucoma. Tras el tratamiento, se observó la desaparición de la blebitis 2 semanas después y resolución de la vitritis 29 días después, con recuperación de la visión a valores previos (20/200). La endoftalmitis por Moraxella nonliquefaciens es rara y está asociada a blebitis de inicio tardío tras una cirugía filtrante de glaucoma. A pesar de la virulencia del cuadro, el pronóstico visual suele ser favorable

Bleb-related endophthalmitis is rare and appears months or years after surgery. The causative agents are usually streptococci or gram-negative bacteria. There are few cases in the literature of endophthalmitis caused by Moraxella nonliquefaciens, and most are delayed-onset associated with blebitis after glaucoma filtration surgery. The case is presented of a 90-year-old patient with endophthalmitis in the right eye due to Moraxella nonliquefaciens associated with blebitis 10 years after glaucoma surgery. After treatment, disappearance of blebitis is observed 2 weeks later and resolution of vitritis 29 days later, with recovery of vision to previous values (20/200). Endophthalmitis due to Moraxella nonliquefaciens is rare, and is associated with late onset blebitis after glaucoma filtration surgery. Despite the virulence of the clinical symptoms, the visual prognosis is usually favourable

Patología neurológica en una unidad de cuidados intensivos pediátricos de tercer nivel. Evolución funcional. Nuestra experiencia / Functional progression of patients with neurological diseases in a tertiary paediatric intensive care unit: Our experience

INTRODUCCIÓN: La enfermedad neurológica representa una parte importante en las unidades de cuidados intensivos pediátricos (UCIP) y es causa de morbimortalidad. El objetivo de este trabajo es analizar la evolución funcional del niño crítico con enfermedad neurológica. MATERIAL Y MÉTODO: Estudio retrospectivo descriptivo, de niños con enfermedad neurológica ingresados en una UCIP durante 3 años (2012-2014), valorando pronóstico vital y funcional, al alta y al año del ingreso, según las Categorías de estado general y cerebral pediátrico (CEGP-CECP) y la Escala de estado funcional (FSS). Los resultados se comparan con nuestros datos previos (años 1990-1999) y con los del estudio multicéntrico internacional PANGEA. RESULTADOS: Se estudió a 266 niños. La mortalidad fue del 3%, sin que los modelos PRISM-II y PIM2 muestren capacidad predictiva. La salud funcional refleja empeoramiento clínicamente significativo al alta de UCIP, en el 30% según CEGP, en el 15% según CECP y en el 5% según FSS. Transcurrido un año, la funcionalidad mejora según CEGP-CECP, pero no según FSS. Los niños sin enfermedad neurológica de base presentan afectación funcional en mayor porcentaje, que se mantiene en el tiempo. Comparada con nuestros datos previos, la mortalidad global y neurocrítica disminuye (5,60 vs. 2,1%; p = 0,0003 y 8,44 vs. 2,63%; p = 0,0014, respectivamente). En relación con el estudio multicéntrico PANGEA, tanto la mortalidad como el empeoramiento funcional cerebral del niño neurocrítico son menores en el estudio actual (1,05 vs. 13,32%; p < 0,0001 y 10,47 vs. 23,79%; p < 0,0001, respectivamente). CONCLUSIONES: Alrededor de un tercio de los niños críticos muestran enfermedad neurológica. Un porcentaje importante, sobre todo de niños sin enfermedad neurológica basal, presenta repercusión funcional clínicamente significativa al alta de UCIP y transcurrido un año. La repercusión en el pronóstico funcional del niño crítico apoya la importancia de la neuromonitorización y neuroprotección, medidas necesarias para mejorar la asistencia del niño crítico y la valoración evolutiva de la salud funcional

INTRODUCTION: Neurological diseases explain a considerable proportion of admissions to paediatric intensive care units (PICU), and are a significant cause of morbidity and mortality. This study aims to analyse the functional progression of children with critical neurological conditions. MATERIAL AND METHODS: Retrospective descriptive study of children admitted to PICU with neurological diseases over a period of 3 years (2012-2014), assessing vital and functional prognosis at PICU discharge and at one year according to the Pediatric Cerebral and Overall Performance Category scales (PCPC-POPC) and the Functional Status Scale (FSS). The results are compared with our previous data (1990-1999), and those of the international multicentre PANGEA study. RESULTS: A total of 266 children were studied. The mortality rate was 3%; the PRISM-III and PIM2 models did not show predictive ability. Clinically significant worsening was observed in functional health at discharge in 30% of the sample, according to POPC, 15% according to PCPC, and 5% according to FSS. After one year, functional performance improved according to PCPC-POPC, but not according to FSS. Children with no underlying neurological disease had a higher degree of functional impairment; this was prolonged over time. We observed a decrease in overall and neurocritical mortality compared with our previous data (5.60 vs. 2.1%, P = .0003, and 8.44 vs. 2.63%, P = .0014, respectively). Compared with the PANGEA study, both mortality and cerebral functional impairment in neurocritical children were lower in our study (1.05 vs. 13.32%, P < .0001, and 10.47% vs. 23.79%, P < .0001, respectively). CONCLUSIONS: Nearly one-third of critically ill children have neurological diseases. A significant percentage, mainly children without underlying neurological diseases, had a clinically significant functional impact at PICU discharge and after a year. Neuromonitoring and neuroprotection measures and the evaluation of functional progression are necessary to improve critical child care

Delayed-onset bleb-related endophthalmitis caused by Moraxella nonliquefaciens. / Endoftalmitis de inicio tardío asociada a ampolla de filtración por Moraxella nonliquefaciens.

Bleb-related endophthalmitis is rare and appears months or years after surgery. The causative agents are usually streptococci or gram-negative bacteria. There are few cases in the literature of endophthalmitis caused by Moraxella nonliquefaciens, and most are delayed-onset associated with blebitis after glaucoma filtration surgery. The case is presented of a 90-year-old patient with endophthalmitis in the right eye due to Moraxella nonliquefaciens associated with blebitis 10 years after glaucoma surgery. After treatment, disappearance of blebitis is observed 2weeks later and resolution of vitritis 29 days later, with recovery of vision to previous values (20/200). Endophthalmitis due to Moraxella nonliquefaciens is rare, and is associated with late onset blebitis after glaucoma filtration surgery. Despite the virulence of the clinical symptoms, the visual prognosis is usually favourable.

Valoración funcional tras tratamiento neurointensivo pediátrico. Nueva escala de estado funcional (FSS) / Functional assessment of a series of paediatric patients receiving neurointensive treatment: New Functional status scale

INTRODUCCIÓN: La salud funcional, parámetro adecuado de morbilidad, debería constituir un estándar pronóstico de las unidades de cuidados intensivos pediátricos (UCIP), siendo fundamental el desarrollo de escalas para su valoración. Las categorías de estado global y cerebral pediátrico (CEGP-CECP) se han empleado clásicamente en estudios pediátricos; el desarrollo de la nueva Escala de estado funcional (FSS) busca mejorar la objetividad. El objetivo del trabajo es comprobar si la escala FSS es un instrumento válido frente a la clásica CEGP-CECP, y si, incluso, posee mejores cualidades evaluadoras de la funcionalidad neurológica. PACIENTES Y MÉTODO: Estudio retrospectivo descriptivo de los 266 niños con enfermedad neurológica ingresados en la UCIP durante 3 años (2012-2014). Se valora su salud funcional al alta y tras un año del ingreso en UCIP, según las categorías CEGP-CECP y la nueva FSS, comparando ambas escalas mediante análisis de correlación (Rho de Spearman). RESULTADOS: La comparación de varianzas de FSSglobal en cada intervalo de CEGP muestra buena correlación para todas las comparaciones (p < 0,001), excepto en la categoría «5 = coma-vegetativo». La dispersión de FSSglobal aumenta a medida que lo hace la categoría CEGP. La correlación es similar en la versión neurológica de ambas escalas. DISCUSIÓN: La nueva escala FSS parece ser un método útil para evaluar salud funcional en nuestro medio, tras su comparación con las clásicas categorías CEGP-CECP. La dispersión de los valores de la escala FSS indica falta de precisión del sistema CEGP-CECP, comparado con la nueva escala FSS, más desglosada y objetiva

INTRODUCTION: Functional health, a reliable parameter of the impact of disease, should be used systematically to assess prognosis in paediatric intensive care units (PICU). Developing scales for the assessment of functional health is therefore essential. The Paediatric Overall and Cerebral Performance Category (POPC, PCPC) scales have traditionally been used in paediatric studies. The new Functional Status Scale (FSS) was designed to provide more objective results. This study aims to confirm the validity of the FSS compared to the classic POPC and PCPC scales, and to evaluate whether it may also be superior to the latter in assessing of neurological function. PATIENTS AND METHOD: We conducted a retrospective descriptive study of 266 children with neurological diseases admitted to intensive care between 2012 and 2014. Functional health at discharge and at one year after discharge was evaluated using the PCPC and POPC scales and the new FSS. RESULTS: Global FSS scores were found to be well correlated with all POPC scores (P < .001), except in category 5 (coma/vegetative state). Global FSS score dispersion increases with POPC category. The neurological versions of both scales show a similar correlation. DISCUSSION: Comparison with classic POPC and PCPC categories suggests that the new FSS scale is a useful method for evaluating functional health in our setting. The dispersion of FSS values underlines the poor accuracy of POPC-PCPC compared to the new FSS scale, which is more disaggregated and objective

Functional progression of patients with neurological diseases in a tertiary paediatric intensive care unit: Our experience. / Patología neurológica en una unidad de cuidados intensivos pediátricos de tercer nivel. Evolución funcional. Nuestra experiencia.

INTRODUCTION: Neurological diseases explain a considerable proportion of admissions to paediatric intensive care units (PICU), and are a significant cause of morbidity and mortality. This study aims to analyse the functional progression of children with critical neurological conditions. MATERIAL AND METHODS: Retrospective descriptive study of children admitted to PICU with neurological diseases over a period of 3 years (2012-2014), assessing vital and functional prognosis at PICU discharge and at one year according to the Pediatric Cerebral and Overall Performance Category scales (PCPC-POPC) and the Functional Status Scale (FSS). The results are compared with our previous data (1990-1999), and those of the international multicentre PANGEA study. RESULTS: A total of 266 children were studied. The mortality rate was 3%; the PRISM-III and PIM2 models did not show predictive ability. Clinically significant worsening was observed in functional health at discharge in 30% of the sample, according to POPC, 15% according to PCPC, and 5% according to FSS. After one year, functional performance improved according to PCPC-POPC, but not according to FSS. Children with no underlying neurological disease had a higher degree of functional impairment; this was prolonged over time. We observed a decrease in overall and neurocritical mortality compared with our previous data (5.60 vs. 2.1%, P=.0003, and 8.44 vs. 2.63%, P=.0014, respectively). Compared with the PANGEA study, both mortality and cerebral functional impairment in neurocritical children were lower in our study (1.05 vs. 13.32%, P<.0001, and 10.47% vs. 23.79%, P<.0001, respectively). CONCLUSIONS: Nearly one-third of critically ill children have neurological diseases. A significant percentage, mainly children without underlying neurological diseases, had a clinically significant functional impact at PICU discharge and after a year. Neuromonitoring and neuroprotection measures and the evaluation of functional progression are necessary to improve critical child care.

Functional assessment of a series of paediatric patients receiving neurointensive treatment: New Functional status scale. / Valoración funcional tras tratamiento neurointensivo pediátrico. Nueva escala de estado funcional (FSS).

INTRODUCTION: Functional health, a reliable parameter of the impact of disease, should be used systematically to assess prognosis in paediatric intensive care units (PICU). Developing scales for the assessment of functional health is therefore essential. The Paediatric Overall and Cerebral Performance Category (POPC, PCPC) scales have traditionally been used in paediatric studies. The new Functional Status Scale (FSS) was designed to provide more objective results. This study aims to confirm the validity of the FSS compared to the classic POPC and PCPC scales, and to evaluate whether it may also be superior to the latter in assessing of neurological function. PATIENTS AND METHOD: We conducted a retrospective descriptive study of 266 children with neurological diseases admitted to intensive care between 2012 and 2014. Functional health at discharge and at one year after discharge was evaluated using the PCPC and POPC scales and the new FSS. RESULTS: Global FSS scores were found to be well correlated with all POPC scores (P<.001), except in category 5 (coma/vegetative state). Global FSS score dispersion increases with POPC category. The neurological versions of both scales show a similar correlation. DISCUSSION: Comparison with classic POPC and PCPC categories suggests that the new FSS scale is a useful method for evaluating functional health in our setting. The dispersion of FSS values underlines the poor accuracy of POPC-PCPC compared to the new FSS scale, which is more disaggregated and objective.

Fenotipo en pacientes con discapacidad intelectual y array-CGH patológico / Phenotype in patients with intellectual disability and pathological results in array CGH

Introducción: El retraso global del desarrollo (RGD) y la discapacidad intelectual (DI) son un motivo de consulta frecuente en la consulta de Neuropediatría. Actualmente, la hibridación genómica comparada constituye una de las principales técnicas aplicadas al diagnóstico de esta patología. Resulta útil determinar qué características fenotípicas se asocian a obtener un resultado etiológico en el test genético. Métodos: Se llevó a cabo un estudio ciego pormenorizado de las características clínicas, antropométricas y morfológicas de 80 individuos afectos de DI no explicada y se analizó cuales estaban asociadas a obtener un resultado etiológico en el array-CGH. Resultados: El resultado del array fue patológico en un 27,5% de los casos. Los factores que se asociaron estadísticamente a tener una prueba de array-CGH patológica fueron los antecedentes familiares de DI/RGD (OR: 12,1), la presencia de malformaciones congénitas (OR: 5,33), más de 3 rasgos dismórficos faciales (OR: 20,9) y la hipotonía periférica (OR: 3,25). Conclusiones: Nuestros hallazgos coinciden con otras series publicadas. Por lo tanto, asumimos que la probabilidad de encontrar variación en el número de copias de significado patológico mediante array-CGH aumenta si alguna de las características anteriores está presentes en individuos afectos de DI/RGD (AU)

Introduction: Global developmental delay (GDD) and intellectual disability (ID) are frequent reasons for consultation in paediatric neurology departments. Nowadays, array comparative genomic hybridisation (array-CGH) is one of the most widely used techniques for diagnosing these disorders. Our purpose was to determine the phenotypic features associated with pathological results in this genetic test. Methods: We conducted a blind study of the epidemiological, clinical, anthropometric, and morphological features of 80 patients with unexplained ID to determine which features were associated with pathological results in array-CGH. Results: Pathological results were found in 27.5% of the patients. Factors associated with pathological results in array-CGH were a family history of GDD/ID (OR = 12.1), congenital malformations (OR = 5.33), having more than 3 facial dysmorphic features (OR = 20.9), and hypotonia (OR = 3.25). Conclusions: Our findings are consistent with those reported by other published series. We therefore conclude that the probability of having pathological results in array-CGH increases with the presence of any of the features mentioned above in patients with ID/GDD (AU)

Experiencia con la hoja de información de «epilepsia en la infancia» / Experience with the information sheet of «epilepsy in infancy»

Introducción. En la sección de neuropediatría, se trabaja con hojas de información que pretenden explicar de forma rigurosa los problemas y su seguimiento. La de «la epilepsia en la infancia» se entrega cuando existe sospecha o diagnóstico certero de epilepsia. Método. Se analiza, a través de unas encuestas, el grado de satisfacción y las percepciones de los padres o tutores que recibieron dicha hoja. Resultados. 658 pacientes recibieron la hoja de información desde febrero de 2012 hasta diciembre de 2014. La tasa de respuesta es del 56,8%. El 63,10% de los pacientes que recibieron la hoja de información tenían un diagnóstico definitivo de epilepsia. Un 92,7% está satisfecho de haber recibido la hoja. Solo un 0,3% de los pacientes hubiera preferido no recibir la hoja de información. Conclusiones. La mayoría de padres o tutores de los pacientes con sospecha o diagnóstico de epilepsia se mostraron satisfechos por recibir la hoja de información. La hoja de información de «epilepsia en la infancia» mejora la información y la satisfacción percibida y su evaluación para corregir y mejorar, es necesaria en el proceso de mejora que no tiene punto final (AU)

Introduction. In the Pediatric Neurology service, we work with fact sheets that aim to rigorously explain the problems and their follow—up. The «epilepsy in childhood» fact sheet is given when there is suspicion or accurate diagnosis of epilepsy. Methods. The degree of satisfaction and the perceptions of the parents or guardians who received this sheet were analyzed through surveys. Results. 658 patients received the fact sheet from February 2012 to December 2014. The response rate was 56.8%. 63.10% of the patients who received the information sheet had a definitive diagnosis of epilepsy. 92.7% are satisfied to have received the sheet. Only 0.3% of the patients would have preferred not to receive the fact sheet. Conclusion. The majority of parents or guardians of patients with suspected or diagnosed epilepsy were satisfied by receiving the fact sheet. The «epilepsy in childhood» fact sheet improves information and perceived satisfaction, and its evaluation (to correct and improve it) is necessary in the continua] improvement process (AU)

Evolución fatal por enterovirus A71 / Fatal evolution by enterovirus A71

El enterovirus (EV) A71 es un serotipo de EV aislado, hasta ahora, frecuentemente en infecciones banales en nuestro medio (síndrome febril, enfermedad mano-pie-boca, herpangina...). No era muy frecuente en nuestro país hasta el año 2012 cuando triplicó su incidencia. Últimamente se ha aislado asociando clínica neurológica grave, miocarditis o edema de pulmón y puntualmente exitus lo que ha provocado una alarma social generalizada (AU)

The enterovirus (EV) A71 is a serotype of EV isolated, until now, frequently in banal infections in our environment (febrile syndrome, hand foot mouth disease, herpangina...). It was not very frequent in our country until 2012 when its incidence tripled. Lately it has been isolated associating severe neurological clinic, myocarditis or pulmonary edema and punctually exitus which has provoked a widespread social alarm (AU)

Phenotype in patients with intellectual disability and pathological results in array CGH. / Fenotipo en pacientes con discapacidad intelectual y array-CGH patológico.

INTRODUCTION: Global developmental delay (GDD) and intellectual disability (ID) are frequent reasons for consultation in paediatric neurology departments. Nowadays, array comparative genomic hybridisation (array-CGH) is one of the most widely used techniques for diagnosing these disorders. Our purpose was to determine the phenotypic features associated with pathological results in this genetic test. METHODS: We conducted a blind study of the epidemiological, clinical, anthropometric, and morphological features of 80 patients with unexplained ID to determine which features were associated with pathological results in array-CGH. RESULTS: Pathological results were found in 27.5% of the patients. Factors associated with pathological results in array-CGH were a family history of GDD/ID (OR = 12.1), congenital malformations (OR = 5.33), having more than 3 facial dysmorphic features (OR = 20.9), and hypotonia (OR = 3.25). CONCLUSIONS: Our findings are consistent with those reported by other published series. We therefore conclude that the probability of having pathological results in array-CGH increases with the presence of any of the features mentioned above in patients with ID/GDD.

Estimación de la prevalencia de sobrepeso y obesidad infantil en un sector sanitario de Zaragoza utilizando diferentes estándares de crecimiento / Overweight and obesity prevalence estimates in a population from Zaragoza by using different growth references

OBJETIVOS: Conocer la prevalencia de sobrepeso y obesidad en nuestro medio y objetivar si hay diferencias significativas al utilizar los estándares de crecimiento de Hernández o los de la Organización Mundial de la Salud (OMS). MATERIAL Y MÉTODOS: el 35824 niñas y niños de 2 a 14 años. Para determinar las prevalencias, mediante ambos estándares (Hernández y OMS), se utilizó el índice de masa corporal. Se compararon y se analizaron las diferencias de prevalencias por edad y sexo y con el porcentaje de pacientes que tenían registrado algún diagnóstico de obesidad-sobrepeso en la historia clínica. RESULTADOS: La prevalencia global de sobrepeso-obesidad de 2 a 14 años fue del 17,0% (IC del 95%, 16,1%-18,0%) según estándares de Hernández y del 30,8% (IC del 95%, 29,9%-31,7%) según estándares OMS (obesidad 10,1% y 12,2%, sobrepeso 6,9% y 18,6%, respectivamente). Fue significativamente mayor en varones, según ambos estándares, debido a la mayor prevalencia de obesidad. Con los estándares de Hernández se obtuvieron prevalencias significativamente menores que con los de OMS, en todas las edades y en ambos sexos. Detectamos un bajo porcentaje de registro del diagnóstico (del 3 al 22% a los 2 y 14 años, respectivamente). CONCLUSIONES: En nuestra población, la prevalencia de sobrepeso-obesidad es alta y es mayor en varones. La utilización de los estándares de Hernández infravalora la sobrecarga ponderal, sobre todo porque detecta menos pacientes con sobrepeso, por lo que creemos que sería preferible incorporar los estándares de OMS de forma sistemática a la práctica diaria. El escaso registro del diagnóstico de sobrepeso-obesidad en la historia clínica podría reflejar una escasa percepción del problema por parte de los profesionales

OBJECTIVES: To investigate the prevalence of overweight and obesity among our pediatric population and observe whether the use of different growth references for classification produce significant differences. MATERIAL AND METHODS: A total of 35824 boys and girls aged between 2 and 14 years were included. Body mass index (BMI) was used to calculate the prevalence of overweight-obesity by age and sex. Prevalence was obtained by using a set of national references (Hernández's standards) and the references of World Health Organization (WHO standards). Prevalences were compared for each age and sex subset, as well as with the percentage of patients who had an overweight-obesity diagnosis in the clinical record. RESULTS: The overall prevalence of overweight-obesity among children aged 2 to 14 years was 17.0% (95% CI; 16.1%-18.0%) according to the Hernández standards vs 30.8% (95% CI; 29.9%- 31.7%) according to WHO standards (10.1% vs 12.2% obese, and 6.9% vs 18.6% overweight). It was significantly higher in boys, by both standards, due to the higher prevalence of obesity. By using the Hernández standards the prevalence was significantly lower than by using WHO standards for all ages and for both sexes. A low percentage of patients were found to have an obesity-overweight diagnosis in the clinical record (from 3% to 22% at the ages of 2 and 14 years, respectively). CONCLUSIONS: The prevalence of overweight-obesity in our population is high, especially among boys. Using Hernández standards leads to an under-estimation of the problem, especially because it detects less overweight patients, thus we recommend using the WHO standards in our daily practice. The low number of overweight-obesity diagnoses in the clinical records might reflect that there is little awareness of the problem by the professionals

[Overweight and obesity prevalence estimates in a population from Zaragoza by using different growth references]. / Estimación de la prevalencia de sobrepeso y obesidad infantil en un sector sanitario de Zaragoza utilizando diferentes estándares de crecimiento.

OBJECTIVES: To investigate the prevalence of overweight and obesity among our pediatric population and observe whether the use of different growth references for classification produce significant differences. MATERIAL AND METHODS: A total of 35824 boys and girls aged between 2 and 14 years were included. Body mass index (BMI) was used to calculate the prevalence of overweight-obesity by age and sex. Prevalence was obtained by using a set of national references (Hernández's standards) and the references of World Health Organization (WHO standards). Prevalences were compared for each age and sex subset, as well as with the percentage of patients who had an overweight-obesity diagnosis in the clinical record. RESULTS: The overall prevalence of overweight-obesity among children aged 2 to 14 years was 17.0% (95% CI; 16.1%-18.0%) according to the Hernández standards vs 30.8% (95% CI; 29.9%-31.7%) according to WHO standards (10.1% vs 12.2% obese, and 6.9% vs 18.6% overweight). It was significantly higher in boys, by both standards, due to the higher prevalence of obesity. By using the Hernández standards the prevalence was significantly lower than by using WHO standards for all ages and for both sexes. A low percentage of patients were found to have an obesity-overweight diagnosis in the clinical record (from 3% to 22% at the ages of 2 and 14 years, respectively). CONCLUSIONS: The prevalence of overweight-obesity in our population is high, especially among boys. Using Hernández standards leads to an under-estimation of the problem, especially because it detects less overweight patients, thus we recommend using the WHO standards in our daily practice. The low number of overweight-obesity diagnoses in the clinical records might reflect that there is little awareness of the problem by the professionals.